A real-world data analysis of ocular adverse events linked to anti-VEGF drugs: a WHO-VigiAccess study

• Autori principali: Chen Li (Autore), Yicheng Lu (Autore), Ziyue Song (Autore), Yueqi Liu (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2024-07-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

IntroductionVascular endothelial growth factor (VEGF) is key to wet age-related macular degeneration (wAMD). Anti-VEGF drugs are the main treatment in clinics. This study assessed ocular adverse events (AE) from anti-VEGF drugs in VigiAccess, WHO's database, and compared adverse drug reaction (...